Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prospects for a safe COVID-19 vaccine
Barton F. Haynes, Lawrence Corey, Prabhavathi Fernandes, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 568
Closed Access | Times Cited: 267

Showing 1-25 of 267 citing articles:

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 27, pp. 2603-2615
Open Access | Times Cited: 13697
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Namit Chaudhary, Drew Weissman, Kathryn A. Whitehead
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 11, pp. 817-838
Open Access | Times Cited: 939
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
Stephen J. Thomas, Edson Duarte Moreira, Nicholas Kitchin, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 19, pp. 1761-1773
Open Access | Times Cited: 888
Myocarditis With COVID-19 mRNA Vaccines
Biykem Bozkurt, Ishan Kamat, Peter J. Hotez
Circulation (2021) Vol. 144, Iss. 6, pp. 471-484
Open Access | Times Cited: 533
Challenges and advances in clinical applications of mesenchymal stromal cells
Tian Zhou, Zenan Yuan, Jianyu Weng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 434
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
Dapeng Li, Robert J. Edwards, Kartik Manne, et al.
Cell (2021) Vol. 184, Iss. 16, pp. 4203-4219.e32
Open Access | Times Cited: 277
SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation
David W. Sanders, Chanelle C. Jumper, Paul J. Ackerman, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 191
Social norms and vaccine uptake: College students’ COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine
Scott Graupensperger, Devon Alisa Abdallah, Christine M. Lee
Vaccine (2021) Vol. 39, Iss. 15, pp. 2060-2067
Open Access | Times Cited: 170
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
Yang Li, Ming‐liang Ma, Qing Lei, et al.
Cell Reports (2021) Vol. 34, Iss. 13, pp. 108915-108915
Open Access | Times Cited: 150
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study
Ron Ram, David Hagin, Nino Kikozashvilli, et al.
Transplantation and Cellular Therapy (2021) Vol. 27, Iss. 9, pp. 788-794
Open Access | Times Cited: 144
Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine
Stephen J. Thomas, Edson Duarte Moreira, Nicholas Kitchin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 142
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment
Dapeng Li, Gregory D. Sempowski, Kevin O. Saunders, et al.
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 1-16
Closed Access | Times Cited: 130
Operation Warp Speed: implications for global vaccine security
Jérôme H. Kim, Peter J. Hotez, Carolina Batista, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 7, pp. e1017-e1021
Open Access | Times Cited: 106
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates
Michael Joyce, Hannah A. D. King, Inès Lakhal-Naouar, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 632
Open Access | Times Cited: 106
Factors, enablers and challenges for COVID-19 vaccine development
Jean‐Louis Excler, Mélanie Saville, Lois Privor-Dumm, et al.
BMJ Global Health (2023) Vol. 8, Iss. 6, pp. e011879-e011879
Open Access | Times Cited: 40
COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology
Hyun Jee Han, Chinekwu Sherridan Nwagwu, Obumneme Benneth Anyim, et al.
International Immunopharmacology (2020) Vol. 90, pp. 107247-107247
Open Access | Times Cited: 119
SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice
Jeroen Pollet, Wen‐Hsiang Chen, Leroy Versteeg, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 8, pp. 2356-2366
Open Access | Times Cited: 90
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge
Anthony DiPiazza, Sarah R. Leist, Olubukola M. Abiona, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1869-1882.e6
Open Access | Times Cited: 87
Whole Inactivated Virus and Protein-Based COVID-19 Vaccines
Peter J. Hotez, María Elena Bottazzi
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 55-64
Closed Access | Times Cited: 86
Development and deployment of COVID-19 vaccines for those most vulnerable
Wayne C. Koff, Theodore Schenkelberg, Tere Williams, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 579
Closed Access | Times Cited: 80
A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates
María Pino, Talha Abid, Susan Pereira Ribeiro, et al.
Science Immunology (2021) Vol. 6, Iss. 61
Open Access | Times Cited: 76
COVID-19 mRNA vaccines
Qingrui Huang, Jiawei Zeng, Jinghua Yan
Journal of genetics and genomics/Journal of Genetics and Genomics (2021) Vol. 48, Iss. 2, pp. 107-114
Open Access | Times Cited: 72
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates
Dapeng Li, Robert J. Edwards, Kartik Manne, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 70
Effectiveness of personal protective health behaviour against COVID-19
Chon-Fu Lio, Hou Hon Cheong, Chin Ion Lei, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 68
The Impact of Age Difference on the Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
Jiting Wang, Tong Yue, Duo Li, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 67
Page 1 - Next Page

Scroll to top